blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2543367

EP2543367 - Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  29.11.2013
Database last updated on 31.08.2024
Most recent event   Tooltip29.11.2013Application deemed to be withdrawnpublished on 01.01.2014  [2014/01]
Applicant(s)For all designated states
Paloma Pharmaceuticals, Inc.
37 Neillian Crescent
Jamaica Plain, MA 02130 / US
[2013/02]
Inventor(s)01 / Sherris, David, I.
c/o Paloma Pharmaceuticals, Inc.
37 Neillian Crescent
Jamaica Plain, MA Massachusetts 02130 / US
 [2013/02]
Representative(s)Duffy, Assumpta Dympna
FRKelly
27 Clyde Road
Dublin D04 F838 / IE
[N/P]
Former [2013/02]Duffy, Assumpta Dympna
FRKelly
27 Clyde Road
Ballsbridge
Dublin 4 / IE
Application number, filing date12171847.228.02.2007
[2013/02]
Priority number, dateUS20060777318P28.02.2006         Original published format: US 777318 P
US2006041261827.04.2006         Original published format: US 412618
[2013/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2543367
Date:09.01.2013
Language:EN
[2013/02]
Search report(s)(Supplementary) European search report - dispatched on:EP11.12.2012
ClassificationIPC:A61K31/00, A61K31/37
[2013/02]
CPC:
A61K31/353 (EP,US); A61K31/19 (EP,US); A61K31/352 (EP,US);
A61K31/366 (EP,US); A61K31/37 (EP,US); A61K31/382 (EP,US);
A61K31/473 (EP,US); A61K31/517 (EP,US); A61K8/37 (EP,US);
A61K8/4926 (EP,US); A61K8/4953 (EP,US); A61K8/498 (EP,US);
A61P17/00 (EP); A61P17/02 (EP); A61P17/06 (EP);
A61P17/16 (EP); A61P29/00 (EP); A61P35/00 (EP);
A61P37/08 (EP); A61P39/00 (EP); A61P9/00 (EP);
A61Q17/04 (EP,US); A61Q19/08 (EP,US); Y02A50/30 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2013/02]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:Zusammensetzungen und Verfahren zur Behandlung von durch zelluläre Proliferation und Angiogenese vermittelten Leiden[2013/02]
English:Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis[2013/02]
French:Compositions et méthodes de traitement de maladies caractérisées par la prolifération cellulaire et l'angiogenèse[2013/02]
Examination procedure10.07.2013Application deemed to be withdrawn, date of legal effect  [2014/01]
16.08.2013Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2014/01]
Parent application(s)   TooltipEP07757634.6  / EP1996021
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20070757634) is  14.06.2010
Fees paidRenewal fee
15.10.2012Renewal fee patent year 03
15.10.2012Renewal fee patent year 04
15.10.2012Renewal fee patent year 05
15.10.2012Renewal fee patent year 06
28.02.2013Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[IY]US2002115711  (SCHMIDT JOHNATHAN MARTIN [CA], et al) [I] 1,3-9 * §0001; §0007; §0010; claim 1, claim 4; example 3; §0039; §0046; Fig. 2-4 * [Y] 1,3-9;
 [IY]US2004162281  (BABU YARLAGADDA S [US], et al) [I] 1,3-9 * p. 94, compounds 54, 55; claims 16-20 * [Y] 1,3-9
 [IY]  - SCHMIDT J M ET AL, "Synthesis and evaluation of a novel nonsteroidal-specific endothelial cell proliferation inhibitor", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 46, no. 8, doi:10.1021/JM034007D, ISSN 0022-2623, (20030410), pages 1289 - 1292, (20030315), XP002563534 [I] 1,3-9 * compounds 9a, 10; scheme 2; last § of p. 1289 to second § of p. 1290; penultimate § of section "conclusion" on p. 1291 * [Y] 1,3-9

DOI:   http://dx.doi.org/10.1021/jm034007d
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.